tirzepatide cvot trial SURPASS-CVOT trial: was non-inferior to dulaglutide and superior to putative placebo for reducing the composite of CV death/HF events in patients with T2D and ASCVD. #AHA25 View the slides here: https://t.co/6VQpBHFP2I Tirzepatide Matches Dulaglutide in Large

Retatrutide 30mg Research Pen | Remedium Research UK Premium Retatrutide 30mg / Remedium Research/Research Peptide for Scientific & Laboratory Research The Retatrutide 30mg Research Pen from Remedium Research UK is a premium research-grade peptide supplied in a convenient pre-filled format for laboratory and scientific research

Heres a glimpse of what I discuss: - The mechanisms behind GLP-1 agonists' ability to promote weight loss - New data on body weight changes after discontinuing the drug - Effects of GLP-1 agonists on lean mass and body composition, and the role of protein and resistance training in preserving muscle - Early indications that GLP-1 agonists may help treat substance abuse disorders - More

Curious about microdosing GLP-1s

Treatment is not guaranteed

Incline and decline pressing, rows, step-ups, Bulgarian split squats, and a long list of accessory movements all become available